C O Tacket

971 total citations
10 papers, 747 citations indexed

About

C O Tacket is a scholar working on Endocrinology, Infectious Diseases and Immunology. According to data from OpenAlex, C O Tacket has authored 10 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, 3 papers in Infectious Diseases and 3 papers in Immunology. Recurrent topics in C O Tacket's work include Vibrio bacteria research studies (4 papers), Salmonella and Campylobacter epidemiology (3 papers) and Escherichia coli research studies (3 papers). C O Tacket is often cited by papers focused on Vibrio bacteria research studies (4 papers), Salmonella and Campylobacter epidemiology (3 papers) and Escherichia coli research studies (3 papers). C O Tacket collaborates with scholars based in United States, Switzerland and Peru. C O Tacket's co-authors include Robert Edelman, James B. Kaper, Stanley J. Cryz, Julian M. Ketley, MyronM. Levine, D A Herrington, Ben D. Tall, G Losonsky, Steven B. Binion and Michael J. Roy and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

C O Tacket

10 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C O Tacket United States 9 439 287 165 164 105 10 747
A M Svennerholm Sweden 16 959 2.2× 455 1.6× 258 1.6× 305 1.9× 84 0.8× 19 1.3k
João Ramos Costa Andrade Brazil 19 810 1.8× 555 1.9× 346 2.1× 120 0.7× 160 1.5× 32 1.1k
Anders Kärnell Sweden 16 531 1.2× 553 1.9× 175 1.1× 112 0.7× 108 1.0× 22 881
A. Kaeckenbeeck Belgium 13 315 0.7× 471 1.6× 158 1.0× 60 0.4× 120 1.1× 42 708
K A Birkness United States 18 324 0.7× 310 1.1× 190 1.2× 111 0.7× 264 2.5× 32 987
Yves Germani France 15 414 0.9× 473 1.6× 159 1.0× 36 0.2× 102 1.0× 53 888
Musangu Ngeleka Canada 17 347 0.8× 274 1.0× 298 1.8× 56 0.3× 90 0.9× 36 793
M. A. Linggood United Kingdom 11 660 1.5× 251 0.9× 238 1.4× 83 0.5× 150 1.4× 14 942
Y. L. Lim United States 9 402 0.9× 143 0.5× 115 0.7× 120 0.7× 41 0.4× 9 562
André P. Burnens Switzerland 15 177 0.4× 226 0.8× 222 1.3× 69 0.4× 197 1.9× 24 741

Countries citing papers authored by C O Tacket

Since Specialization
Citations

This map shows the geographic impact of C O Tacket's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C O Tacket with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C O Tacket more than expected).

Fields of papers citing papers by C O Tacket

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C O Tacket. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C O Tacket. The network helps show where C O Tacket may publish in the future.

Co-authorship network of co-authors of C O Tacket

This figure shows the co-authorship network connecting the top 25 collaborators of C O Tacket. A scholar is included among the top collaborators of C O Tacket based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C O Tacket. C O Tacket is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Kanesa-thasan, Niranjan, Robert Edelman, C O Tacket, et al.. (2003). PHASE 1 STUDIES OF WALTER REED ARMY INSTITUTE OF RESEARCH CANDIDATE ATTENUATED DENGUE VACCINES: SELECTION OF SAFE AND IMMUNOGENIC MONOVALENT VACCINES. American Journal of Tropical Medicine and Hygiene. 69(6_suppl). 17–23. 45 indexed citations
3.
Tacket, C O, Karen L. Kotloff, G Losonsky, et al.. (1997). Volunteer Studies Investigating the Safety and Efficacy of Live Oral El Tor Vibrio cholerae O1 Vaccine Strain CVD 111. American Journal of Tropical Medicine and Hygiene. 56(5). 533–537. 42 indexed citations
4.
Taylor, David N., C O Tacket, G Losonsky, et al.. (1997). Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infection and Immunity. 65(9). 3852–3856. 40 indexed citations
5.
6.
Morris, J. Glenn, Marcelo B. Sztein, Eugene W. Rice, et al.. (1996). Vibrio cholerae 01 Can Assume a Chlorine-Resistant Rugose Survival Form that Is Virulent for Humans. The Journal of Infectious Diseases. 174(6). 1364–1368. 92 indexed citations
7.
Keay, Susan, C O Tacket, James R. Murphy, & Barry S. Handwerger. (1992). Anti-CD4 Anti-Idiotype Antibodies in Volunteers Immunized with rgp 160 of HIV-1 or Infected with HIV-1. AIDS Research and Human Retroviruses. 8(6). 1091–1098. 13 indexed citations
8.
Tacket, C O, Steven B. Binion, Eileen F. Bostwick, et al.. (1992). Efficacy of Bovine Milk Immunoglobulin Concentrate in Preventing Illness after Shigella Flexneri Challenge. American Journal of Tropical Medicine and Hygiene. 47(3). 276–283. 141 indexed citations
9.
Archibald, David W., Carla Hebert, Di Sun, & C O Tacket. (1990). Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial.. PubMed. 3(10). 954–8. 15 indexed citations
10.
Levine, MyronM., D A Herrington, Ben D. Tall, et al.. (1988). SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR. The Lancet. 332(8609). 467–470. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026